Gleevec 00078-0649
Generic: Imatinib Mesylate
Product NDC
00078-0649- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 23, 2014
- Listing Expires
- December 31, 2027
- Application
- NDA021588
Need to source Gleevec? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Imatinib Mesylate | 400 mg/1 |
Drug Class
Bcr-Abl Tyrosine Kinase Inhibitors [MoA]Cytochrome P450 2D6 Inhibitors [MoA]Cytochrome P450 3A4 Inhibitors [MoA]
Packaging Options(2)
3 BLISTER PACK in 1 CARTON (0078-0649-13) / 10 TABLET in 1 BLISTER PACK (0078-0649-26)
30 TABLET in 1 BOX, UNIT-DOSE (0078-0649-30)